The XIX International Workshop on iwCLL will now be fully virtual in 2021.
The iwCLL organizing committee has made this decision out of an abundance of caution for everyone’s health and safety.
While this change was unexpected and we regret that we will not be able to connect with you in person, we view this as an opportunity to innovate. The committee has diligently worked on an interactive and engaging agenda. The iwCLL biennial international meeting continues to be committed to advancing the field of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders through thought-provoking discussions, debates, and virtual networking.
This program runs through 5 days:
Please continue to check the website for updates. We hope that you will be able to join us in this new virtual format, even if you were not originally planning to make the trip to Krakow.
30 July 2021 – Industry-Supported Virtual Satellite Symposia Application Deadline
01 August 2021 – Abstract Late-Breakers Open
04 August 2021 – YIM & iwCLL Abstract Notifications
23 August 2021 – Abstract Late-Breakers Closed
27 August 2021 – Abstract Titles and Authors Released on Website
01 September 2021 – Late-Breakers Notifications
09 September 2021 – On-Demand Presentations Available on Virtual Platform
13 September 2021 – Late-Breakers and Full Abstracts Released on Virtual Platform
The live virtual experience will include top experts sharing highlights from over 25 on-demand presentations, available 9 September 2021. The on-demand presentations will be available through the virtual platform. These interactive panel discussions will also feature debates and Q&A from the live audience.
8:00 AM (EDT) | 14:00 (GMT +2) (CEST) | Young Investigator Meeting |
9:00 AM (EDT) | 15:00 (GMT +2) (CEST) | Welcome & Introductions |
9:05 AM (EDT) | 15:05 (GMT +2) (CEST) | Session 1: Molecular Pathogenesis of CLL – Genomics and Proteomics |
10:00 AM (EDT) | 16:00 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
10:05 AM (EDT) | 16:05 (GMT +2) (CEST) | Session 2: Molecular Pathogenesis of CLL – Microenvironment and Signaling |
11:00 AM (EDT) | 17:00 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
11:05 AM (EDT) | 17:05 (GMT +2) (CEST) | Session 3: Clonal Dynamics, Competition, and Disease Evolution |
12:00 PM (EDT) | 18:00 (GMT +2) (CEST) | End of Day 1 |
12:00 PM (EDT) | 18:00 (GMT +2) (CEST) | Poster Session |
9:00 AM (EDT) | 15:00 (GMT +2) (CEST) | Opening Remarks & Recap of Previous Day |
9:05 AM (EDT) | 15:05 (GMT +2) (CEST) | Session 4: Prognostication and Prediction in the Era of Novel Drugs |
10:15 AM (EDT) | 16:15 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
10:20 AM (EDT) | 16:20 (GMT +2) (CEST) | Session 5: Minimal Residual Disease – Methods and Clinical Application |
11:30 AM (EDT) | 17:30 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
11:35 AM (EDT) | 17:35 (GMT +2) (CEST) | Industry-Supported Symposia |
12:35 PM (EDT) | 18:35 (GMT +2) (CEST) | Binet/Rai Medal Presentation |
12:45 PM (EDT) | 18:45 (GMT +2) (CEST) | Session 6: Front-Line Therapy of CLL |
1:40 PM (EDT) | 19:40 (GMT +2) (CEST) | End of Day 2 |
1:40 PM (EDT) | 19:40 (GMT +2) (CEST) | Poster Session |
7:45 AM (EDT) | 13:45 (GMT +2) (CEST) | Industry-Supported Symposia |
9:00 AM (EDT) | 15:00 (GMT +2) (CEST) | Opening Remarks & Recap of Previous Day |
9:05 AM (EDT) | 15:05 (GMT +2) (CEST) | Session 7: Treatment of Relapsed/Refractory CLL |
10:00 AM (EDT) | 16:00 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
10:05 AM (EDT) | 16:05 (GMT +2) (CEST) | Session 8: New Agents in CLL Clinical Trials |
11:00 AM (EDT) | 17:00 (GMT +2) (CEST) | Industry-Supported Symposia |
12:00 AM (EDT) | 18:00 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
12:05 PM (EDT) | 18:05 (GMT +2) (CEST) | Session 9: Immunotherapy of CLL |
1:30 PM (EDT) | 19:30 (GMT +2) (CEST) | End of Day 3 |
1:30 PM (EDT) | 19:30 (GMT +2) (CEST) | Poster Session |
9:00 AM (EDT) | 15:00 (GMT +2) (CEST) | Opening Remarks & Recap of Previous Day |
9:05 AM (EDT) | 15:05 (GMT +2) (CEST) | Session 10: Supportive Care and Consequences of Immune Dysregulation in CLL |
9:55 AM (EDT) | 15:55 (GMT +2) (CEST) | Industry-Supported Symposia |
10:55 AM (EDT) | 16:55 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
11:00 AM (EDT) | 17:00 (GMT +2) (CEST) | Session 11: Real-World Data and Patient Experiences |
12:08 AM (EDT) | 18:08 (GMT +2) (CEST) | Visit Virtual Exhibit Hall & Break |
12:15 PM (EDT) | 18:15 (GMT +2) (CEST) | Session 11: Real-World Data and Patient Experiences, Continued |
1:00 PM (EDT) | 19:00 (GMT +2) (CEST) | Session 12: Looking to the Future of CLL and iwCLL |
1:05 PM (EDT) | 19:05 (GMT +2) (CEST) | Keynote: Advances in CLL: Is It Time to Talk Cure? |
1:55 PM (EDT) | 19:55 (GMT +2) (CEST) | Close of Workshop |